Our Story

Since our inception, we have been dedicated to creating innovative software solutions that tackle critical challenges in the breast cancer screening process. By improving the quality of care, we strive to transform cancer detection and treatment, ensuring better health outcomes for patients, greater efficiency for healthcare providers and cost savings for payors.

Mission

Whiterabbit’s mission is to make late-stage breast cancer a rarity by detecting it early through the power of AI. We aim to revolutionize the screening paradigm by removing barriers to adoption and enhancing collaboration between artificial and human intelligence for better patient outcomes.

Vision

Transform breast cancer screening by eliminating clinical, operational, and financial barriers to AI adoption in breast imaging, ensuring better outcomes for all stakeholders.

Goals

Expand equitable access to early breast cancer detection by delivering AI-powered tools that integrate seamlessly into clinical workflows and support radiologists in delivering faster, more accurate care.

Our Journey

Clinic Operations

In the early days of the company, we owned and operated 9 outpatient radiology sites, developing within our DNA a deep appreciation of clinical operations and constraints.

This early operational experience helped us understand the needs and pain points of our direct customers and theirs, the patient.

Research and Development

We continue to advance our mission with several patents pending and products in development that stem from a proprietary data set across more than 2 million patients and partnerships with industry leading institutions. At the core of it all is our exceptional team of over 50 AI scientists, engineers, and innovative healthcare professionals.

Collaborations with industry-leading institutions

To make our mission a reality, we needed a premier dataset to drive the efficacy and accuracy of our products. Collaborating with leading academic and professional institutions has been essential since day one. Our collaborators continue to play a pivotal role as we build on our suite of groundbreaking and life-changing products.

At Whiterabbit, we're harnessing the power of AI to transform breast cancer screening, operating in a space where artificial intelligence and human intelligence intersect.

After a career dedicated to advancing early detection, I’m proud to lead a team pushing the boundaries of what’s possible. Our people are our greatest strength and with them, we’re redefining how mammography is perceived, delivered, and interpreted for the benefit of patients and providers alike.

Alexander Sardiña, MD

CEO

The Whiterabbit Team

Whiterabbit is a venture-backed AI company based in Silicon Valley, focused on advancing early detection and improving diagnostic accuracy in breast cancer care. Our leadership team comprises seasoned executives from healthcare, clinical operations, science, and technology, while our board and advisors include distinguished leaders from healthcare, software, insurance, radiology, and breast cancer research.